Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwok Chi Lam

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Urology|August 21, 2002
Chemotherapy induced complete remission in malignant phyllodes tumor of the prostate metastasizing to the lungKwok Chi Lam, Winnie Yeo
Respirology (Carlton, Vic.)|August 21, 2010
Targeted therapy: an evolving world of lung cancerKwok-Chi Lam, Tony S Mok
Thoracic Cancer|September 19, 2017
Management of malignant pleural effusion: Options and recommended approachesLinda Leung, Michael Hsin, Kwok Chi Lam
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
The diverse diversityTony S K Mok, Kwok Chi Lam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Treating patients with EGFR-sensitizing mutations: first line or second line--is there a difference?Tony Mok, Jin-Ji Yang, Kwok-Chi Lam
Asia-Pacific Journal of Clinical Oncology|August 24, 2012
Non-small cell lung cancer: One size doesn't fit allLinda Leung, Kwok Chi Lam, Tony S K Mok
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinomaKirsty W C Lee, Amy B W Chan, Anthony W I Lo, et al.
Oncology|July 16, 2005
Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancerTony S K Mok, Kwok Chi Lam, Conrad Lee, et al.
Investigational New Drugs|September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsBrigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Sequential chemotherapy with combination irinotecan and cisplatin followed by docetaxel for treatment-naïve patients with advanced non-small cell lung cancerTony S K Mok, Simon Ho, Gong Chan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Urology|August 21, 2002
Chemotherapy induced complete remission in malignant phyllodes tumor of the prostate metastasizing to the lungKwok Chi Lam, Winnie Yeo
Respirology (Carlton, Vic.)|August 21, 2010
Targeted therapy: an evolving world of lung cancerKwok-Chi Lam, Tony S Mok
Thoracic Cancer|September 19, 2017
Management of malignant pleural effusion: Options and recommended approachesLinda Leung, Michael Hsin, Kwok Chi Lam
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
The diverse diversityTony S K Mok, Kwok Chi Lam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Treating patients with EGFR-sensitizing mutations: first line or second line--is there a difference?Tony Mok, Jin-Ji Yang, Kwok-Chi Lam
Asia-Pacific Journal of Clinical Oncology|August 24, 2012
Non-small cell lung cancer: One size doesn't fit allLinda Leung, Kwok Chi Lam, Tony S K Mok
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinomaKirsty W C Lee, Amy B W Chan, Anthony W I Lo, et al.
Oncology|July 16, 2005
Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancerTony S K Mok, Kwok Chi Lam, Conrad Lee, et al.
Investigational New Drugs|September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsBrigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Sequential chemotherapy with combination irinotecan and cisplatin followed by docetaxel for treatment-naïve patients with advanced non-small cell lung cancerTony S K Mok, Simon Ho, Gong Chan, et al.
Pageof 2